ABIOMED (ABMD): $1.43 million was the positive money flow into the stock on Thursday and the up/down ratio of ticks was also in favor of the bulls at 1.3. The value of trades done on upticks was $6.17 million, whereas, trades done on downticks were valued at $4.74 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $0.1 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $0.1 million. ABIOMED (ABMD) fell $0.51 traded at $117, a change of -0.43% over the previous day. The stock is 2.5% for the week.
The stock has recorded a 20-day Moving Average of 9.72% and the 50-Day Moving Average is 15.33%. Shares have rallied 70.73% from its 1 Year high price. On Jul 11, 2016, the shares registered one year high at $116.71 and the one year low was seen on Jul 15, 2015. The 50-Day Moving Average price is $103.87 and the 200 Day Moving Average price is recorded at $92.99.
ABIOMED (NASDAQ:ABMD): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $118.39 and $116.94 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $118.69. The buying momentum continued till the end and the stock did not give up its gains. It closed at $117.78, notching a gain of 0.23% for the day. The total traded volume was 480,559 . The stock had closed at $117.51 on the previous day.
In an insider trading activity, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the Officer (Vp, Global Sales & Marketing) of ABIOMED INC, Howley Michael G had sold 10,000 shares worth of $1,065,800 in a transaction dated June 29, 2016. In this transaction, 10,000 shares were sold at $106.58 per share.
Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Companys products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.